tonsillopharyngitis%20-%20acute%20(pediatric)
TONSILLOPHARYNGITIS - ACUTE (PEDIATRIC)
Tonsillopharyngitis is the inflammation of the tonsils and pharynx.
Etiologies include bacterial and viral pathogens.
Sore throat is the most common presenting symptom in older children.

Surgical Intervention

  • For recurrent tonsillopharyngitis, surgery aims reduction in occurrence of sore throat & improved general health with tonsillectomy
Indications for Tonsillectomy
Recurrent tonsillitis
  • Sore throat due to inflammation of tonsils
  • ≥7 episodes of tonsillitis over a 12-month period or ≥5 episodes/year in the past 2 years or ≥3 episodes/year in the past 3 years
  • Symptoms interfere with patient’s normal daily function
Peritonsillar abscess or quinsy
  • All abscesses should be drained
  • Tonsillectomy if without response to appropriate antibiotics &/or incision & drainage
Contraindications to Tonsillectomy
  • Velopharyngeal insufficiency, hematologic factors (anemia, etc) & presence of local infection
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
04 Apr 2018
Early progressive feeding is feasible and effective in increasing the number of full enteral feeding days in extremely preterm infants, suggests a recent study.
Tristan Manalac, 06 Apr 2018
Receptivity to any tobacco advertising is high among adolescents, and e-cigarette advertising is the most effective, reports a recent US study, which also shows that receptivity to advertising is associated with progression to use.
21 Mar 2018
Dr Elizabeth Carpenter, Principal Scientist of Dairy Goat Co-operative (DGC) in New Zealand, spoke to MIMS about goat milk as a source of protein in childhood nutrition. Below are highlights from the interview.
Pearl Toh, 05 Apr 2018
Adding tiotropium to inhaled corticosteroids (ICS) appeared safe and well tolerated in preschool children with persistent asthmatic symptoms, reveals an exploratory, regulatory trial—suggesting that tiotropium may be a complementary strategy for managing this young population for whom treatment options are scarce.